BofA upgraded Sabra Health Care to Neutral from Underperform with a price target of $14, up from $11.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on SBRA: